518 related articles for article (PubMed ID: 17055663)
1. Morphine priming in rats with chronic inflammation reveals a dichotomy between antihyperalgesic and antinociceptive properties of deltorphin.
Gendron L; Esdaile MJ; Mennicken F; Pan H; O'Donnell D; Vincent JP; Devi LA; Cahill CM; Stroh T; Beaudet A
Neuroscience; 2007 Jan; 144(1):263-74. PubMed ID: 17055663
[TBL] [Abstract][Full Text] [Related]
2. Differential noxious and motor tolerance of chronic delta opioid receptor agonists in rodents.
Beaudry H; Proteau-Gagné A; Li S; Dory Y; Chavkin C; Gendron L
Neuroscience; 2009 Jun; 161(2):381-91. PubMed ID: 19328839
[TBL] [Abstract][Full Text] [Related]
3. Morphine-induced changes in delta opioid receptor trafficking are linked to somatosensory processing in the rat spinal cord.
Morinville A; Cahill CM; Aibak H; Rymar VV; Pradhan A; Hoffert C; Mennicken F; Stroh T; Sadikot AF; O'Donnell D; Clarke PB; Collier B; Henry JL; Vincent JP; Beaudet A
J Neurosci; 2004 Jun; 24(24):5549-59. PubMed ID: 15201327
[TBL] [Abstract][Full Text] [Related]
4. Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain.
Holdridge SV; Cahill CM
Eur J Pain; 2007 Aug; 11(6):685-93. PubMed ID: 17175187
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation and trafficking of delta opioid receptor in a model of chronic inflammation: implications for pain control.
Cahill CM; Morinville A; Hoffert C; O'Donnell D; Beaudet A
Pain; 2003 Jan; 101(1-2):199-208. PubMed ID: 12507715
[TBL] [Abstract][Full Text] [Related]
6. Regulation of delta-opioid receptor trafficking via mu-opioid receptor stimulation: evidence from mu-opioid receptor knock-out mice.
Morinville A; Cahill CM; Esdaile MJ; Aibak H; Collier B; Kieffer BL; Beaudet A
J Neurosci; 2003 Jun; 23(12):4888-98. PubMed ID: 12832511
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms responsible for the enhanced antinociceptive effects of micro-opioid receptor agonists in the rostral ventromedial medulla of male rats with persistent inflammatory pain.
Sykes KT; White SR; Hurley RW; Mizoguchi H; Tseng LF; Hammond DL
J Pharmacol Exp Ther; 2007 Aug; 322(2):813-21. PubMed ID: 17494863
[TBL] [Abstract][Full Text] [Related]
8. Removing TRPV1-expressing primary afferent neurons potentiates the spinal analgesic effect of delta-opioid agonists on mechano-nociception.
Chen SR; Pan HL
Neuropharmacology; 2008 Aug; 55(2):215-22. PubMed ID: 18579164
[TBL] [Abstract][Full Text] [Related]
9. Essential role of mu opioid receptor in the regulation of delta opioid receptor-mediated antihyperalgesia.
Gendron L; Pintar JE; Chavkin C
Neuroscience; 2007 Dec; 150(4):807-17. PubMed ID: 17997230
[TBL] [Abstract][Full Text] [Related]
10. Endomorphin-2, deltorphin II and their analogs suppress formalin-induced nociception and c-Fos expression in the rat spinal cord.
Labuz D; Chocyk A; Wedzony K; Toth G; Przewlocka B
Life Sci; 2003 Jun; 73(4):403-12. PubMed ID: 12759135
[TBL] [Abstract][Full Text] [Related]
11. Spinal dynorphin and bradykinin receptors maintain inflammatory hyperalgesia.
Luo MC; Chen Q; Ossipov MH; Rankin DR; Porreca F; Lai J
J Pain; 2008 Dec; 9(12):1096-105. PubMed ID: 18976961
[TBL] [Abstract][Full Text] [Related]
12. Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice.
Szentirmay AK; Király KP; Lenkey N; Lackó E; Al-Khrasani M; Friedmann T; Timár J; Gyarmati S; Tóth G; Fürst S; Riba P
Brain Res Bull; 2013 Jan; 90():66-71. PubMed ID: 22995282
[TBL] [Abstract][Full Text] [Related]
13. Antinociceptive and antihyperalgesic effects of tapentadol in animal models of inflammatory pain.
Schiene K; De Vry J; Tzschentke TM
J Pharmacol Exp Ther; 2011 Nov; 339(2):537-44. PubMed ID: 21816956
[TBL] [Abstract][Full Text] [Related]
14. Antinociceptive and morphine modulatory actions of spinal orphanin FQ.
Jhamandas KH; Sutak M; Henderson G
Can J Physiol Pharmacol; 1998 Mar; 76(3):314-24. PubMed ID: 9673795
[TBL] [Abstract][Full Text] [Related]
15. Mu-opioid receptor knockout prevents changes in delta-opioid receptor trafficking induced by chronic inflammatory pain.
Morinville A; Cahill CM; Kieffer B; Collier B; Beaudet A
Pain; 2004 Jun; 109(3):266-273. PubMed ID: 15157687
[TBL] [Abstract][Full Text] [Related]
16. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
[TBL] [Abstract][Full Text] [Related]
17. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
Chen SR; Pan HL
J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418
[TBL] [Abstract][Full Text] [Related]
18. Increased tumor necrosis factor-alpha and prostaglandin E2 concentrations in the cerebrospinal fluid of rats with inflammatory hyperalgesia: the effects of analgesic drugs.
Bianchi M; Martucci C; Ferrario P; Franchi S; Sacerdote P
Anesth Analg; 2007 Apr; 104(4):949-54. PubMed ID: 17377112
[TBL] [Abstract][Full Text] [Related]
19. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
20. Peripheral antinociceptive effects of mu- and delta-opioid receptor agonists in NOS2 and NOS1 knockout mice during chronic inflammatory pain.
Leánez S; Hervera A; Pol O
Eur J Pharmacol; 2009 Jan; 602(1):41-9. PubMed ID: 19041302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
